Horizon eBook - 2

RESEARCH SERVICES

OncoSignature HTS Platform

Screen Your Compounds Against
300 Cancer Cell Lines
Reveal the antiproliferative signature of your
compounds as single agents or in combination across
300 cancer cell lines
Our OncoSignature HT Screening Platform allows you to profile your compounds
of interest as mono or combination therapy across a comprehensive panel of 300
cancer cell lines, including isogenic cell lines.
Study drug response, compare activity against 200 oncology reference
compounds, identify combination interactions and aid in identifying the best
patient population for your drug candidate or drug combination.

To learn more about OncoSignature visit:

info.horizondiscovery.com/oncosignature



http://info.horizondiscovery.com/oncosignature http://info.horizondiscovery.com/oncosignature

Horizon eBook

Table of Contents for the Digital Edition of Horizon eBook

Contents
Horizon eBook - 1
Horizon eBook - 2
Horizon eBook - 3
Horizon eBook - Contents
Horizon eBook - 5
Horizon eBook - 6
Horizon eBook - 7
Horizon eBook - 8
Horizon eBook - 9
Horizon eBook - 10
Horizon eBook - 11
Horizon eBook - 12
Horizon eBook - 13
Horizon eBook - 14
Horizon eBook - 15
Horizon eBook - 16
Horizon eBook - 17
Horizon eBook - 18
Horizon eBook - 19
Horizon eBook - 20
Horizon eBook - 21
Horizon eBook - 22
Horizon eBook - 23
Horizon eBook - 24
https://www.nxtbookmedia.com